Ipca - Ranbaxy Alliance receives U.S. FDA Marketing Approval for Metoclopramide Tablets.	June 17, 2008
	Ipca receive U.S. FDA Approval For Propranolol Hydrochloride Tablets	June 4, 2008
	Financial Results	May 29, 2008
	Ipca is now expanding their global footprint.	April 6, 2008
	MHRA-UK Certifies 3rd plant of Ipca Laboratories Ltd.	March 24, 2008
	Ipca's Fourth Clinical Trial Gets Published in a Peer Reviewed Journal	February 5, 2008
	Financials Results	January 19, 2008
	Ipca has received the Second Prize in "National Energy Conservation Award" for 2007	December 14, 2007
	Ipca Laboratories launches new pain killer drug	December 4, 2007
	Ipca has been awarded by Forbes Inc., as one of the ‘Best Under a Billion Forbes Global’s 200 Best Small Companies, 2007’. In the past, we have been awarded, for three consecutive years’ 2003, 2004, 2005.	November 22, 2007
	Financial Results	October 29, 2007
	Ipca’s anti-malarial product – Artesunate tablets 50 mg pre-qualified by WHO.	September 14, 2007
	Acquisition of 100% Shareholding of Formulation Dossier Registration Holding Companies in Australia and New Zealand.	September 13, 2007
	CDRI Licenses Novel Anti Malarial Compound to IPCA.	August 27, 2007
	Ipca - Ranbaxy Alliance Receive U.S. FDA Marketing Approval For Metformin HCL Tablets.	August 13, 2007
	Ipca – Ranbaxy Alliance receive U.S. FDA marketing approval for Hydrochlorothiazide Tablets.	July 23, 2007
	Financial Results	July 20, 2007
	Ipca granted U.S.FDA approval for Hydroxychloroquine Sulfate Tablets.	June 19, 2007
	Financial Results	May 25, 2007
	Ipca files to DCGI - India First Investigational New Drug Application (INDA) in collaboration with Central Drug Research Institute (CDRI), Lucknow	February 5, 2007
	Q3 - Financial Results	January 23, 2007
	Ipca - Ranbaxy Alliance receive U.S.FDA Marketing approval for Atenolol Tablets	January 2, 2007
	Ipca's Bulk Drug 'Atenolol' Registered in China	December 29, 2006
	Ipca launches fixed dose ACT combination and stops manufacturing of single ingredient Oral Artemisinin derivatives.	October 6, 2006
	Ipca Laboratories Ltd. enters into strategic alliance with Ranbaxy Pharmaceuticals Inc., for the U.S Market	21 September, 2006
	New plant at Dehradun	5 May, 2006
	Ipca enters into Joint Venture with Holley Group of China	29 April, 2005
	Life Time Achievement Award from CHEMEXCIL	05 January, 2005
	Ipca acquires Cardiac brand 'ISORDIL'	10 January, 2005
	CDRI licenses novel Anti Malarial compound to Ipca	30 November, 2004
	Ipca, 'Best under a Billion' for the second consecutive year	01 November, 2004
	Four more APIs for USA	09 August, 2004
	Trishul	04 August, 2004
	"Best Under a Billion" award by Forbes	02 August, 2003